FDA Hammers Columbia Doc's Clinical Trial Oversight
The U.S. Food and Drug Administration on Tuesday published a stern warning letter accusing a Columbia University Medical Center physician of poor clinical trial oversight that allegedly included excessive delegation of...To view the full article, register now.
Already a subscriber? Click here to view full article